Press Releases

Filter

Filter Results

Year

Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare Press Release Image

Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare

Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure Press Release Image

Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath Press Release Image

U.S. FDA Grants 510(k) Clearance for Impella Low Profile Sheath

Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support Press Release Image

Yale University Study Demonstrates Significant Survival Benefit in High-Risk PCI with Impella Support

Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77% Press Release Image

Multi-Center, Multi-Society Study of Impella®-Supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81% Press Release Image

Large, Multi-Center, Multi-Society Study of Impella-supported Patients Finds 30-day AMI Cardiogenic Shock Survival of 81%

Unloading with Impella for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients Press Release Image

Unloading with Impella® for 30 Minutes Before PCI Associated with Reduced Infarct Size in STEMI Patients

FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC) Press Release Image

FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent (EFIC)

TCT 2022: Impella Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery Press Release Image

TCT 2022: Impella® Enables Complete Revascularization, Improved Quality of Life and Native Heart Recovery

Restore EF Study Shows Heart Function, Symptom Improvements for High-Risk PCI Patients Supported by Impella Press Release Image

RESTORE EF Study Shows Heart Function, Symptom Improvements for High-Risk PCI Patients Supported by Impella®

ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency* Press Release Image

ABIOMED Announces First Quarter Record Revenue of $277 Million, up 10% Year Over Year, up 12% in Constant Currency*  

SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes Press Release Image

SCAI 2022 Scientific Sessions Highlight Impella Research, Advancements to Improve Cardiogenic Shock Outcomes

World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump Press Release Image

World’s First Patient Implanted with Impella BTR™ Minimally Invasive Heart Pump

First Patient in Japan Treated with Impella 5.5 with SmartAssist Press Release Image

First Patient in Japan Treated with Impella 5.5® with SmartAssist®

Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year Press Release Image

Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year

The Protected PCI community
is now on HeartRecovery.com

Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
Explore Now